25.01.2013 Views

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

160 8 Interleukin-10 in <strong>Cancer</strong> Immunity<br />

sensitive towards this cytokine. This is due to the down-regulation of IL-10Ra upon<br />

T cell activation [20]. The interaction between CD28 <strong>and</strong> IL-10Ra seems to be essential<br />

for the influence of IL-10 on these cells [61]. The presence of IL-10 during the activation<br />

of CD4 + T cells results in the development of a regulatory phenotype of these<br />

cells [62±65]. It is characterized <strong>by</strong> weak proliferation <strong>and</strong> a specific cytokine profile<br />

after repeated stimulation. Typical for these cells is also their capacity to transfer this<br />

phenotype to other T cells with the same antigen specificity. This transfer may not be<br />

dependent on soluble mediators, but on cell surface molecules [66]. Whether the influence<br />

of IL-10 on CD4 + T cells or on APC in vivo is the most important in the generation<br />

of such regulatory cells remains to be clarified. In vitro, both pathways have<br />

been demonstrated. IL-10 does not exert potent direct inhibitory effects on CD8 + T<br />

cells. It can even activate CD8 + T cells under certain conditions [67, 68].<br />

8.3.3<br />

Effectson Natural Killer (NK) Cells<br />

The effect of IL-10 on NK cells is mainly stimulatory. IL-10 favors the cytotoxic activity<br />

of these cells. It increases the IL-2-induced production of cytokines such as IFN-g,<br />

GM-CSF <strong>and</strong> TNF-a. Furthermore, it amplifies the IL-2-induced proliferation of the<br />

CD56 bright NK cell subpopulation [18]. Moreover, IL-10 augments the ability of IL-18<br />

to stimulate NK cells [69].<br />

8.3.4<br />

Effectson other <strong>Immune</strong> Cells<br />

IL-10 has various, but weak stimulatory effects on B cells. It prevents apoptosis <strong>and</strong> enhances<br />

the proliferation <strong>and</strong> differentiation towards plasma cells [70, 71]. It also plays<br />

a role in Ig switching. In combination with IL-4 it induces IgG4 but inhibits IgE production;<br />

in combination with TGF-b, IL-10 induces IgA1 <strong>and</strong> IgA2 secretion [72, 73].<br />

Very similar to monocytes <strong>and</strong> macrophages, IL-10 in granulocytes inhibits the production<br />

of pro-inflammatory (TNF-a <strong>and</strong> IL-1b) <strong>and</strong> induces the production of antiinflammatory<br />

(IL-1RA) mediators. Moreover, it inhibits the release of various chemokines<br />

<strong>by</strong> neutrophils [74, 75]. The synthesis of cyclooxygenase-2 as well as the production<br />

of prostagl<strong>and</strong>in E2 is also inhibited <strong>by</strong> IL-10 [76]. Another effect of IL-10 is<br />

the inhibition of lipopolysaccharide (LPS)-induced synthesis of pro-inflammatory<br />

mediators in eosinophils <strong>and</strong> mast cells [77, 78]. In combination with IL-3 <strong>and</strong> IL-4,<br />

however, IL-10 favors the growth of mast cells [79].<br />

8.3.5<br />

IL-10'sRole in the <strong>Immune</strong> System<br />

Most generally, the immune system can either be divided into the specific <strong>and</strong> the<br />

unspecific or into the humoral <strong>and</strong> the cellular system. The role of IL-10 particularly<br />

concerns the inhibition of the unspecific humoral immunity due to its effects on<br />

monocytes, macrophages <strong>and</strong> also granulocytes. IL-10 exerts inhibitory effects on

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!